Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
-
Publication Venue For
-
Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IV..
68:1823-1830.
2019
-
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection..
67:1477-1492.
2018
-
Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection.
2018
-
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1..
66:1222-1229.
2018
-
Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis..
64:1619-1621.
2017
-
Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group..
64:S24-S29.
2017
-
Statin Utilization and Recommendations Among HIV- and HCV-infected Veterans: A Cohort Study..
63:407-413.
2016
-
The Typhoid Fever Surveillance in Africa Program (TSAP): Clinical, Diagnostic, and Epidemiological Methodologies..
62 Suppl 1:S9-S16.
2016
-
Utilization of Healthcare in the Typhoid Fever Surveillance in Africa Program..
62 Suppl 1:S56-S68.
2016
-
Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II..
62:181-189.
2016
-
RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration..
61Suppl 3:S155-S159.
2015
-
Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study..
61:527-535.
2015
-
Point-of-prescription interventions to improve antimicrobial stewardship..
60:1252-1258.
2015
-
Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study..
60:741-749.
2015
-
Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureus..
60:787-796.
2015
-
Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study..
60:254-262.
2015
-
Invasive gram-positive bacterial infection in cancer patients..
59 Suppl 5:S331-S334.
2014
-
Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America..
59:e96-138.
2014
-
Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections..
59:798-807.
2014
-
Invasive Salmonella infections in areas of high and low malaria transmission intensity in Tanzania..
58:638-647.
2014
-
Methicillin-resistant Staphylococcus aureus: an evolving pathogen..
58 Suppl 1:S10-S19.
2014
-
Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations..
56:1724-1732.
2013
-
Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke..
56:209-217.
2013
-
Reply to Seddon, Schaaf, and Hesseling..
56:168-169.
2013
-
Fool's gold: Why imperfect reference tests are undermining the evaluation of novel diagnostics: a reevaluation of 5 diagnostic tests for leptospirosis..
55:322-331.
2012
-
Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis..
55:572-581.
2012
-
Bacteremic disseminated tuberculosis in sub-saharan Africa: a prospective cohort study..
55:242-250.
2012
-
Outcomes following candiduria in extremely low birth weight infants..
54:331-339.
2012
-
Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens..
52:31-40.
2011
-
Unrecognized pretransplant and donor‐derived cryptococcal disease in organ transplant recipients..
51:1062-1069.
2010
-
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection..
51:641-650.
2010
-
Factors associated with mortality in transplant patients with invasive aspergillosis..
50:1559-1567.
2010
-
Synergistic pandemics: confronting the global HIV and tuberculosis epidemics..
50 Suppl 3:S67-S70.
2010
-
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)..
50:1101-1111.
2010
-
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database..
50:1091-1100.
2010
-
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America..
48:503-535.
2009
-
Epidemiology of methicillin-resistant Staphylococcus aureus..
46 Suppl 5:S344-S349.
2008
-
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms..
46:1683-1693.
2008
-
Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen..
46:e12-e18.
2008
-
Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania..
45:1492-1498.
2007
-
Extensively drug-resistant tuberculosis: are we learning from history or repeating it?.
45:338-342.
2007
-
Early surgery in patients with infective endocarditis: a propensity score analysis..
44:364-372.
2007
-
Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia..
44:190-196.
2007
-
Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration..
43:783-786.
2006
-
A man with chronic leg edema, purpuric skin lesions, and abdominal lymphadenopathy..
41.
2005
-
Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment..
39:e70-e73.
2004
-
Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database..
38:1323-1327.
2004
-
Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi..
37:221-229.
2003
-
Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens..
36:858-862.
2003
-
Advances against aspergillosis..
37 Suppl 3.
2003
-
The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis..
33:1824-1833.
2001